Parameter
| Biomarker | Gal-3 | Full name | Galectin-3 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Early diagnosis、Prognostic judgment、Early warning of complications | ||
| Disease | Chronic Kidney Disease (CKD) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Urine, blood ( protein detection, ELISA) | ||
| Pathobiological Mechanisms | It promotes renal fibrosis and inflammatory response, and is associated with cardiovascular risk. | ||||
| Clinical Availability Status | Some clinical applications / Research verification stage | ||||
| Notes and Dynamics | It is negatively correlated with eGFR in patients with diabetic nephropathy, which can be used as an early warning indicator of CKD complicated with cardiovascular disease, and has both renal and cardiovascular risk assessment value. | ||||